A randomized comparative study on the effectiveness of the original long-acting betamethasone dipropionate and its generic form in patients with plantar fasciitis
Open Access
- 24 June 2026
- journal article
- Published by Publishing House Zaslavsky in TRAUMA
- Vol. 27 (3) , 274-280
Abstract
Background. Plantar fasciitis is a chronic condition and one of the most common causes of heel pain. Despite a wide range of available treatment options, a significant proportion of patients experience long-term symptoms that limit their functional activity and quality of life. The purpose was to compare the clinical effectiveness of the original long-acting betamethasone dipropionate and its generic form in the treatment of patients with plantar fasciitis. Materials and methods. A prospective randomized study was conducted in 60 patients with plantar fasciitis, allocated into two groups in a 1 : 1 ratio. Participants in the study group received a local injection of the original drug, while patients in the comparison group received the generic formulation. Pain intensity, complication rate, local changes assessed by ultrasound, and the need for repeat injection were evaluated. Assessments were performed at baseline, on days 7 and 28. Results. Statistically lower pain intensity scores were observed in patients of the study group both on day 7 (2.03 ± 0.61 points vs 2.63 ± 0.85 points; p = 0.009) and on day 28 of the follow-up (1.37 ± 0.72 points vs 1.97 ± 0.89 points; p = 0.03). The relative reduction in pain in the study group was 70.40 ± 8.07 % on day 7 and 80.54 ± 9.74 % on day 28, as opposed to 60.46 ± 12.04 % and 70.52 ± 12.88 %, respectively, in the comparison group. No local complications or pathological ultrasound changes were recorded in the study group. In the comparison group, local complications were observed in 2 (6.67 %) patients, while ultrasound changes were detected in 4 (13.33 %) people. However, differences between the groups were statistically significant only in terms of the frequency of pathological changes as determined by ultrasound (p = 0.04). No patients in the study group required repeat injection during the follow-up period, in contrast to the comparison group, where the corresponding rate was 20.00 % (p = 0.02). Conclusions. Original long-acting betamethasone dipropionate demonstrated a statistically lower level of residual pain on days 7 and 28, a greater relative reduction in pain intensity, and no need for repeat injection during the follow-up period compared to the generic formulation. Regarding the frequency of local complications and pathological ultrasound changes, a trend in favor of the original preparation was observed.Keywords
This publication has 9 references indexed in Scilit:
- Efficacy and Safety of Dextrose Prolotherapy Versus Corticosteroid Injections in Plantar Fasciitis: A Systematic Review and Meta‐AnalysisJournal of Foot and Ankle Research, 2026
- Comparative effectiveness of minimally invasive therapies for plantar fasciitis: a systematic review and network meta-analysisScientific Reports, 2026
- Comparative efficacy of corticosteroid injection, extracorporeal shock wave therapy, and radiofrequency ablation for chronic plantar fasciitis: a prospective randomized controlled trialBMC Musculoskeletal Disorders, 2026
- OUTCOMES FOLLOWING CORTICOSTEROID INJECTIONS IN PATIENTS WITH PLANTAR FASCIITISPakistan Journal of Intensive Care Medicine, 2025
- A Comparative Study of Platelet-Rich Plasma V/S Corticosteroid Injection for Plantar FasciitisJournal of Pharmacy and Bioallied Sciences, 2025
- The role of corticosteroid injections in treating plantar fasciitis: A systematic review and meta-analysisThe Foot, 2023
- A prospective study to assess the effectiveness of corticosteroid injection in the treatment of chronic plantar fasciitisInternational Journal of Orthopaedics Sciences, 2022
- Development and Validation of a Discriminative Dissolution Test for Betamethasone Sodium Phosphate and Betamethasone Dipropionate Intramuscular Injectable SuspensionAAPS PharmSciTech, 2013
- MEASUREMENT OF PAINThe Lancet, 1974